Immunobiology of NKT cell development and function
Immunobiology of NKT cell development and function
批准号:
8099344
负责人:
Derek B. Sant'Angelo
金额:
$22.09万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-07-12 至 2011-06-30
关键词:
Autoimmune DiseasesBiologyBone MarrowCancer ControlCell physiologyCell surfaceCellsCellular biologyCommitDataDependencyDevelopmentDiseaseEventFamilyGenesGoalsImmuneImmune responseImmune systemImmunobiologyInbred NOD MiceInsulin-Dependent Diabetes MellitusLabelLearningLigandsMemoryMethodsMusMutagenesisNamesNatural Killer CellsNatureOrgan Culture TechniquesPathway interactionsPeripheralPhenotypePopulationPropertyProtein KinasePublishingRegulationRoleSeriesSignal TransductionSystemT-Cell DevelopmentT-LymphocyteTCR ActivationTechniquesThymus GlandTissuesTransgenesTravelWorkchemical geneticscytokinedesignfightinggene therapykiller T cellmembermouse modelmutantnovelprecursor cellprogenitorreceptorreceptor expressionresearch studyretroviral-mediatedsrc-Family Kinasesthymocytetooltumor
中文摘要
不变的自然杀伤T细胞(iNKT细胞)是一种罕见但有效的细胞群,表达免疫调节功能。
自然杀伤细胞和T细胞都有这些CD 1d限制性细胞已被证明是
积极和消极地调节免疫反应。iNKT细胞的作用范围从对抗肿瘤到
抑制或治愈各种自身免疫性疾病。这些细胞有很多特征
与常规T细胞不同,包括它们在免疫后释放大量细胞因子的能力。
初级活化,高度限制的TCR库,活化或记忆表型,
NK细胞的典型受体和外周组织中的不均匀分布,仅举几例。
iNKT细胞在胸腺中发育的有力证据最近才得到证实。知之甚少
关于这些细胞的早期发育,除了它似乎与传统的T细胞不同之外,
发展我们建议研究iNKT细胞发育的几个方面,从分析
TCR是一项下游信号事件的研究,旨在理解和潜在地操纵TCR。
这些细胞的发育。我们将首先表征iNKTCR与
CD 1d来了解这种非常强的TCR-配体相互作用的生物学如何帮助定义
iNKT细胞。在目标2中,我们提出分析Src家族蛋白的关键和可能独特的功能
激酶、Fyn在iNKT细胞发育中的作用。对菲恩的研究将指导我们寻找第二个
我们认为这是iNKT细胞发育所必需的受体。这项工作还将寻求调节iNKT细胞
通过控制它们在胸腺中发育的各个方面来发挥作用。最后,在目标3中,我们将开发一种方法,
在iNKT细胞发育的非常早期,可能在细胞表面表达前,
TCR。这种方法将为我们提供一个工具,以表征和探索的机制,iNKT细胞
发展
总之,这些研究将有助于我们对iNKT细胞的几个关键方面的基本理解,
生物学了解iNKT细胞发育的关键方面将最终使改变细胞的生长成为可能。
这些细胞的功能使用基因治疗的方法,努力控制癌症和其他疾病。
英文摘要
Invariant Natural Killer T cells (iNKT cells) are a rare but potent population of cells expressing features in
common with both natural killer cells and T cells. These CD1d restricted cells have been shown to both
positively and negatively modulate immune responses. Roles for iNKT cells range from fighting tumors to
suppressing or curing various autoimmune diseases. The cells have numerous features that make them
distinct from conventional T cells including their ability to release copious amounts of cytokines following
primary activation, a highly restricted TCR repertoire, an activated or memory phenotype, expression of
receptors typical of NK cells and unequal distribution in peripheral tissues, to name a few.
Definitive proof that iNKT cells develop in the thymus has only recently been established. Little is known
about the early development of these cells other than that it appears to be distinct from conventional T cell
development. We propose to study several aspects of iNKT cell development ranging from an analysis of the
TCR to a study of downstream signaling events in an effort to understand and potentially manipulate the
development of these cells. We will first characterize properties of the unusual interaction of the iNKTCR with
CD1d to learn how the biology of this remarkably strong TCR-ligand interaction helps define the function of
iNKT cells. In Aim 2 we propose to analyze the critical and possibly unique function of the Src-family protein
kinase, Fyn in iNKT cell development. The studies of Fyn will guide our search for a proposed second
receptor that we believe is required for iNKT cell development. This work will also seek to modulate iNKT cell
function by controlling aspects of their development in the thymus. Finally, in Aim 3, we will develop a method
to tag developing iNKT cells very early in their development, perhaps prior to cell surface expression of the
TCR. This approach will give us a tool to characterize and explore the mechanisms underlying iNKT cell
development.
Overall, these studies will contribute to our basic understanding of several critical aspects of iNKT cell
biology. Understanding key aspects of iNKT cell development will eventually make it possible to alter the
function of these cells using gene therapy approaches in an effort to control cancer and other diseases.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
A transgenic TCR directs the development of IL-4+ and PLZF+ innate CD4 T cells.
转基因 TCR 指导 IL-4 和 PLZF 先天 CD4 T 细胞的发育。
DOI:
10.4049/jimmunol.1300862
发表时间:
2013
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
[Zhu,Lingqiao, Qiao,Yu, Choi,EstherS, Das,Joy, Sant'angelo,DerekB, Chang,Cheong-Hee]
通讯作者:
Chang,Cheong-Hee
Direct identification of rat iNKT cells reveals remarkable similarities to human iNKT cells and a profound deficiency in LEW rats.
对大鼠 iNKT 细胞的直接鉴定揭示了与人类 iNKT 细胞的显着相似性以及 LEW 大鼠中的严重缺陷。
DOI:
10.1002/eji.201242565
发表时间:
2013
期刊:
European journal of immunology
影响因子:
5.4
作者:
[Monzon-Casanova,Elisa, Paletta,Daniel, Starick,Lisa, Müller,Ingrid, Sant'Angelo,DerekB, Pyz,Elwira, Herrmann,Thomas]
通讯作者:
Herrmann,Thomas
DOI:
10.4049/jimmunol.1900068
发表时间:
2019-09-01
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
[Zhang S, Vieth JA, Krzyzanowska A, Henry EK, Denzin LK, Siracusa MC, Sant'Angelo DB]
通讯作者:
Sant'Angelo DB
DOI:
10.1038/ni.1641
发表时间:
2008-09
期刊:
Nature immunology
影响因子:
30.5
作者:
[]
通讯作者:
DOI:
10.1371/journal.pone.0024441
发表时间:
2011
期刊:
PloS one
影响因子:
3.7
作者:
[Eidson M, Wahlstrom J, Beaulieu AM, Zaidi B, Carsons SE, Crow PK, Yuan J, Wolchok JD, Horsthemke B, Wieczorek D, Sant'Angelo DB]
通讯作者:
Sant'Angelo DB
共 9 条
PLZF expression in adipose resident natural killer T cells
-
批准号:10364677
-
项目类别:
-
资助金额:$19.63万
-
财政年份:2021
-
负责人:Derek B. Sant'Angelo
-
依托单位:
PLZF expression in adipose resident natural killer T cells
-
批准号:10189318
-
项目类别:
-
资助金额:$23.5万
-
财政年份:2021
-
负责人:Derek B. Sant'Angelo
-
依托单位:
Contribution of Innate-like Tregs for Preventing Tissue Inflammation
-
批准号:10412729
-
项目类别:
-
资助金额:$23.21万
-
财政年份:2021
-
负责人:Derek B. Sant'Angelo
-
依托单位:
Expression of BTB-ZF Transcriptional Regulators as Biomarkers of Immune System Development
-
批准号:9092587
-
项目类别:
-
资助金额:$7.95万
-
财政年份:2016
-
负责人:Derek B. Sant'Angelo
-
依托单位:
Control of cytokine production by human NK cells
-
批准号:8987712
-
项目类别:
-
资助金额:$19.69万
-
财政年份:2015
-
负责人:Derek B. Sant'Angelo
-
依托单位:
The function of PLZF in innate T cells
-
批准号:8724069
-
项目类别:
-
资助金额:$7.15万
-
财政年份:2013
-
负责人:Derek B. Sant'Angelo
-
依托单位:
Leukocyte subset identification by single cell analysis of BTB-ZF gene
-
批准号:8705813
-
项目类别:
-
资助金额:$9.33万
-
财政年份:2013
-
负责人:Derek B. Sant'Angelo
-
依托单位:
The function of PLZF in innate T cells
-
批准号:8701749
-
项目类别:
-
资助金额:$32.21万
-
财政年份:2013
-
负责人:Derek B. Sant'Angelo
-
依托单位:
Leukocyte subset identification by single cell analysis of BTB-ZF gene
-
批准号:8444930
-
项目类别:
-
资助金额:$10.49万
-
财政年份:2013
-
负责人:Derek B. Sant'Angelo
-
依托单位:
The function of PLZF in innate T cells
-
批准号:8318421
-
项目类别:
-
资助金额:$28.55万
-
财政年份:2010
-
负责人:Derek B. Sant'Angelo
-
依托单位:
The function of PLZF in innate T cells
-
批准号:8278688
-
项目类别:
-
资助金额:$38.61万
-
财政年份:2010
-
负责人:Derek B. Sant'Angelo
-
依托单位:
The function of PLZF in innate T cells
-
批准号:8468634
-
项目类别:
-
资助金额:$4.73万
-
财政年份:2010
-
负责人:Derek B. Sant'Angelo
-
依托单位:
The function of PLZF in innate T cells
-
批准号:8074349
-
项目类别:
-
资助金额:$12.31万
-
财政年份:2010
-
负责人:Derek B. Sant'Angelo
-
依托单位:
The function of PLZF in innate T cells
-
批准号:7993318
-
项目类别:
-
资助金额:$47.73万
-
财政年份:2010
-
负责人:Derek B. Sant'Angelo
-
依托单位:
The function of the NKT cell determinant, PLZF, in mucosal lymphocytes.
-
批准号:7713256
-
项目类别:
-
资助金额:$33.25万
-
财政年份:2009
-
负责人:Derek B. Sant'Angelo
-
依托单位:
The function of the NKT cell determinant, PLZF, in mucosal lymphocytes.
-
批准号:7924611
-
项目类别:
-
资助金额:$18.81万
-
财政年份:2009
-
负责人:Derek B. Sant'Angelo
-
依托单位:
Immunobiology of NKT cell development and function
-
批准号:7151180
-
项目类别:
-
资助金额:$44.91万
-
财政年份:2005
-
负责人:Derek B. Sant'Angelo
-
依托单位:
Immunobiology of NKT cell development and function
-
批准号:7534984
-
项目类别:
-
资助金额:$50.52万
-
财政年份:2005
-
负责人:Derek B. Sant'Angelo
-
依托单位:
Immunobiology of NKT cell development and function
-
批准号:7319655
-
项目类别:
-
资助金额:$44.06万
-
财政年份:2005
-
负责人:Derek B. Sant'Angelo
-
依托单位:
Immunobiology of NKT cell development and function
-
批准号:7028712
-
项目类别:
-
资助金额:$43.87万
-
财政年份:2005
-
负责人:Derek B. Sant'Angelo
-
依托单位:
国内基金
海外基金
Journal of Integrative Plant Biology
-
批准号:31024801
-
项目类别:专项基金项目
-
资助金额:24.0万元
-
批准年份:2010
-
负责人:贺萍
-
依托单位: